Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 124
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    MyHealthEd

    Each child deserves quality comprehensive sexual health education. No child is the same, so why...

    Do fungi exposed to toxic waste produce novel antimicrobial agents?

    We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

    Are endangered tigers in Nepal threatened by diseases from dogs and cats?

    Through our wildlife health work in Nepal, we have seen sick tigers that show symptoms similar to canine...

    Backer Badge Funded